Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

T Monschein; S Dekany; T Zrzavy; M Ponleitner; P Altmann; G Bsteh; B Kornek; P Rommer; C Enzinger; F Di Pauli; Jörg Kraus; T Berger; F Leutmezer; M Guger; Austrian MS Treatment Registry AMSTR

doi:10.1007/s00415-023-11784-1

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

T Monschein
, S Dekany
, T Zrzavy
, M Ponleitner
, P Altmann
, G Bsteh
, B Kornek
, P Rommer
, C Enzinger
, F Di Pauli
, Jörg Kraus (Co-Autor/-in)
, T Berger
, F Leutmezer
, M Guger
, Austrian MS Treatment Registry AMSTR

Universitätsinstitut für Medizinisch-Chemische Labordiagnostik

Publikation: Beitrag in Fachzeitschrift › Korrektur › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	3787
Fachzeitschrift	JOURNAL OF NEUROLOGY
Jahrgang	270
Ausgabenummer	8
DOIs	https://doi.org/10.1007/s00415-023-11784-1
Publikationsstatus	Veröffentlicht - Aug. 2023

Zugriff auf Dokument

10.1007/s00415-023-11784-1

Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
Monschein, T., Dekany, S., Zrzavy, T., Ponleitner, M., Altmann, P., Bsteh, G., Kornek, B., Rommer, P., Enzinger, C., Di Pauli, F., Kraus, J. (Co-Autor/-in), Berger, T., Leutmezer, F. & Guger, M., 2023, in: JOURNAL OF NEUROLOGY .
Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

4 Quellenangaben (Web of Science)

Dieses zitieren

Monschein, T., Dekany, S., Zrzavy, T., Ponleitner, M., Altmann, P., Bsteh, G., Kornek, B., Rommer, P., Enzinger, C., Di Pauli, F., Kraus, J., Berger, T., Leutmezer, F., Guger, M., & Austrian MS Treatment Registry AMSTR (2023). Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR). JOURNAL OF NEUROLOGY , 270(8), 3787. https://doi.org/10.1007/s00415-023-11784-1

Monschein, T ; Dekany, S ; Zrzavy, T et al. / Correction : Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR). in: JOURNAL OF NEUROLOGY 2023 ; Jahrgang 270, Nr. 8. S. 3787.

@article{49269d8664b6455487b865e98af73473,

title = "Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)",

author = "T Monschein and S Dekany and T Zrzavy and M Ponleitner and P Altmann and G Bsteh and B Kornek and P Rommer and C Enzinger and \{Di Pauli\}, F and J{\"o}rg Kraus and T Berger and F Leutmezer and M Guger and \{Austrian MS Treatment Registry AMSTR\}",

note = "Kraus: Department of Laboratory Medicine, Paracelsus Medical University and Salzburger Landeskliniken, Salzburg, Austria",

year = "2023",

month = aug,

doi = "10.1007/s00415-023-11784-1",

language = "English",

volume = "270",

pages = "3787",

journal = "JOURNAL OF NEUROLOGY ",

issn = "0340-5354",

publisher = "Springer Nature",

number = "8",

}

Monschein, T, Dekany, S, Zrzavy, T, Ponleitner, M, Altmann, P, Bsteh, G, Kornek, B, Rommer, P, Enzinger, C, Di Pauli, F, Kraus, J, Berger, T, Leutmezer, F, Guger, M & Austrian MS Treatment Registry AMSTR 2023, 'Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)', JOURNAL OF NEUROLOGY , Jg. 270, Nr. 8, S. 3787. https://doi.org/10.1007/s00415-023-11784-1

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR). / Monschein, T; Dekany, S; Zrzavy, T et al.
in: JOURNAL OF NEUROLOGY , Jahrgang 270, Nr. 8, 08.2023, S. 3787.

Publikation: Beitrag in Fachzeitschrift › Korrektur › Begutachtung

TY - JOUR

T1 - Correction

T2 - Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

AU - Monschein, T

AU - Dekany, S

AU - Zrzavy, T

AU - Ponleitner, M

AU - Altmann, P

AU - Bsteh, G

AU - Kornek, B

AU - Rommer, P

AU - Enzinger, C

AU - Di Pauli, F

AU - Kraus, Jörg

AU - Berger, T

AU - Leutmezer, F

AU - Guger, M

AU - Austrian MS Treatment Registry AMSTR, null

N1 - Kraus: Department of Laboratory Medicine, Paracelsus Medical University and Salzburger Landeskliniken, Salzburg, Austria

PY - 2023/8

Y1 - 2023/8

U2 - 10.1007/s00415-023-11784-1

DO - 10.1007/s00415-023-11784-1

M3 - Correction

C2 - 37272963

SN - 0340-5354

VL - 270

SP - 3787

JO - JOURNAL OF NEUROLOGY

JF - JOURNAL OF NEUROLOGY

IS - 8

ER -

Monschein T, Dekany S, Zrzavy T, Ponleitner M, Altmann P, Bsteh G et al. Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR). JOURNAL OF NEUROLOGY . 2023 Aug;270(8):3787. doi: 10.1007/s00415-023-11784-1

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

Zugriff auf Dokument

Publikationen

Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

Dieses zitieren